The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8071288 B1

PDF
Full Text
Expired
Date of Patent:
Dec. 06, 2011

Filed:

Feb. 12, 2008
Applicants:

Larry Gold, Boulder, CO (US);

Jonathan Drew Smith, Boulder, CO (US);

Dominic Zichi, Boulder, CO (US);

Daniel J. Schneider, Arvada, CO (US);

Chad Greef, Louisville, CO (US);

Inventors:

Larry Gold, Boulder, CO (US);

Jonathan Drew Smith, Boulder, CO (US);

Dominic Zichi, Boulder, CO (US);

Daniel J. Schneider, Arvada, CO (US);

Chad Greef, Louisville, CO (US);

Assignee:

SomaLogic, Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides novel methods and reagents for detecting the binding of protein targets to nucleic acid ligands. Using Universal Protein Stains (UPS), proteins bound by nucleic acid ligands may be labeled with a detectable moiety. The methods and reagents are particularly useful for the detection of protein targets bound to multiplexed arrays of nucleic acid ligands. The present invention also provides novel methods for the multiplexed evaluation of photocrosslinking nucleic acid ligands. The methods allow one simultaneously to: (1) evaluate the performance (dynamic range) of a plurality of photocrosslinking nucleic acid ligands; and (2) assess the specificity of each photocrosslinking nucleic acid ligand for its cognate target protein. Photocrosslinking nucleic acid ligands with the most desirable properties can then be selected for use in diagnostic and prognostic medical assays. The present invention also provides a photocrosslinking nucleic acid ligand that binds specifically to HIV gp120MN.


Find Patent Forward Citations

Loading…